Literature DB >> 29565721

Automated Insulin Delivery Systems: Hopes and Expectations of Family Members.

Kimberly P Garza1, Aneta Jedraszko1, Lindsey E G Weil2, Diana Naranjo3, Katharine D Barnard4, Lori M B Laffel5, Korey K Hood3,6, Jill Weissberg-Benchell1,2.   

Abstract

BACKGROUND: This study examines the hopes and expectations that children, adolescents, and adults with type 1 diabetes and their families have for new automated insulin delivery systems. The study also aims to examine how the automated insulin delivery system may impact family functioning and individual members' psychosocial adjustment.
METHODS: Forty-eight semistructured focus groups (n = 195) and 89 individual interviews were conducted with children, adolescents, and adults with type 1 diabetes and parents and partners. Coders reviewed results in key themes most likely to contain references to the family system. Clusters were analyzed using thematic analysis to identify participants' salient hopes and expectations of how new technology may impact family relationships and individual psychosocial functioning.
RESULTS: Three main themes emerged for participants' hopes and expectations for implementation of the automated insulin delivery system. First, there is an expectation that this diabetes technology will alleviate diabetes-specific worry and burden for the people with diabetes and other family members. Second, there is also hope that this system may reduce day-to-day stress and, third, improve family relationships.
CONCLUSIONS: The unique perspective of a broad age group provides insight into how individuals and families creatively address the multiple tasks required in daily diabetes management. Study findings elucidate the very high hopes and expectations held by those managing type 1 diabetes and the impact this new technology may have on family relationships. Awareness of these hopes and expectations is important for developers and clinicians in addressing potential challenges to uptake and to ensure that expectations are set appropriately.

Entities:  

Keywords:  Family systems.; Technology; Type 1 diabetes

Mesh:

Substances:

Year:  2018        PMID: 29565721      PMCID: PMC6422006          DOI: 10.1089/dia.2017.0301

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  8 in total

1.  Successful At-Home Use of the Tandem Control-IQ Artificial Pancreas System in Young Children During a Randomized Controlled Trial.

Authors:  Gregory P Forlenza; Laya Ekhlaspour; Marc Breton; David M Maahs; R Paul Wadwa; Mark DeBoer; Laurel H Messer; Marissa Town; Jennifer Pinnata; Geoff Kruse; Bruce A Buckingham; Daniel Cherñavvsky
Journal:  Diabetes Technol Ther       Date:  2019-03-19       Impact factor: 6.118

2.  Design and Clinical Evaluation of the Interoperable Artificial Pancreas System (iAPS) Smartphone App: Interoperable Components with Modular Design for Progressive Artificial Pancreas Research and Development.

Authors:  Sunil Deshpande; Jordan E Pinsker; Stamatina Zavitsanou; Dawei Shi; Randy Tompot; Mei Mei Church; Camille Andre; Francis J Doyle; Eyal Dassau
Journal:  Diabetes Technol Ther       Date:  2018-12-14       Impact factor: 6.118

3.  Realizing a Closed-Loop (Artificial Pancreas) System for the Treatment of Type 1 Diabetes.

Authors:  Rayhan A Lal; Laya Ekhlaspour; Korey Hood; Bruce Buckingham
Journal:  Endocr Rev       Date:  2019-12-01       Impact factor: 19.871

4.  Clinical Implementation of the Omnipod 5 Automated Insulin Delivery System: Key Considerations for Training and Onboarding People With Diabetes.

Authors:  Cari Berget; Jennifer L Sherr; Daniel J DeSalvo; Ryan S Kingman; Sheri L Stone; Sue A Brown; Alex Nguyen; Leslie Barrett; Trang T Ly; Gregory P Forlenza
Journal:  Clin Diabetes       Date:  2022-04-15

5.  Perceptions and expectations of adults with type 1 diabetes for the use of artificial pancreas systems with and without glucagon addition: Results of an online survey.

Authors:  Nadine Taleb; Ariane Quintal; Rohan Rakheja; Virginie Messier; Laurent Legault; Eric Racine; Rémi Rabasa-Lhoret
Journal:  Nutr Metab Cardiovasc Dis       Date:  2020-10-17       Impact factor: 4.222

6.  Innovative features and functionalities of an artificial pancreas system: What do youth and parents want?

Authors:  Persis V Commissariat; Lisa K Volkening; Deborah A Butler; Eyal Dassau; Stuart A Weinzimer; Lori M Laffel
Journal:  Diabet Med       Date:  2021-01-20       Impact factor: 4.213

7.  Safety Evaluation of the MiniMed 670G System in Children 7-13 Years of Age with Type 1 Diabetes.

Authors:  Gregory P Forlenza; Orit Pinhas-Hamiel; David R Liljenquist; Dorothy I Shulman; Timothy S Bailey; Bruce W Bode; Michael A Wood; Bruce A Buckingham; Kevin B Kaiserman; John Shin; Suiying Huang; Scott W Lee; Francine R Kaufman
Journal:  Diabetes Technol Ther       Date:  2018-12-26       Impact factor: 6.118

8.  Youth and parent preferences for an ideal AP system: It is all about reducing burden.

Authors:  Persis V Commissariat; Lindsay C Roethke; Jennifer L Finnegan; Zijing Guo; Lisa K Volkening; Deborah A Butler; Eyal Dassau; Stuart A Weinzimer; Lori M Laffel
Journal:  Pediatr Diabetes       Date:  2021-08-09       Impact factor: 4.866

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.